Public insight portal
Prescription, organisation and demographic data are available to the public through 'Catalyst' our new online application.
To gain access to 'Catalyst', you will be required to input an ID and password:
- ID - NHSBSAGuest
- Password - Password1234
If the password is locked for any reason the system automatically reinstates the password. This may take up to 20 minutes.
Important information and updates
NHS Clinical Commissioning Group (CCG) reorganisation as of 1 April 2021
Changes due to the CCG reorganisation have been implemented with effect from April 2021 dispensing data and have been implemented across all our reporting systems where applicable - Information Services Portal (ISP), Open Data Portal (OPD) and ePACT2. Read more about the changes and how it affects our systems and reports (Word: 64KB).
BNF Code Changes January 2021
The annual BNF version changes were implemented with January 2021 dispensing data released in March 2021. Read more about the changes and how it affects our systems and reports.
Reports available to view
You can view the following reports at practice level:
- Controlled drugs
- Prescribing monitoring
- Prescribing comparators
- Cost comparators
- Volume comparators
- Advance Flu Report - Pharmacy Contractors
Organisational and demographic information is also available.
Dashboards available to view
Valproate prescribing in female patients under 55 dashboard
Working in collaboration with the NHS England and NHS Improvement Valproate Safety Implementation Group (VSIG), we’ve developed a set of prescribing indicators to track the use of valproate medicines among women of childbearing potential (WCP).
For the purposes of these comparators, WCP is interpreted as females between the ages of 13 and 54 years. Information is also provided on valproate prescribing for girls between the ages of 0 and 12 who may continue treatment in later years.
Valproate prescribing in pregnancy has shown to increase the risk of physical birth defects and neurodevelopmental disorders in unborn babies. Guidance from MHRA suggests that valproate should not be used in WCP unless other treatments are ineffective or not tolerated.
The indicators identify the number of WCP who are receiving valproate medication. The data can be used to analyse prescribing patterns, to support a reduction in the use of valproate in WCP, and to help prevent unplanned pregnancies in women taking valproate.
You can read more about the valproate prescribing in the female patients under 55 Dashboard.
Antimicrobial Stewardship - RightCare UTI Focus Pack dashboard
The metrics reported in this dashboard have been developed by the RightCare programme in collaboration with NHS England and NHS Improvement and are designed to support Clinical Commissioning Group (CCG) led improvement in the management of lower urinary tract infection (UTI) in people aged 70 and over.
Antimicrobial Stewardship - RightCare UTI comparators show prescribing patterns for patients treated with antibiotics for UTIs. Clinicians developed them to support better prescribing. They let you see variation and identify areas of interest for further investigation and patient review. They do not show good or bad prescribing.
Electronic Prescription Service (EPS) and electronic Repeat Dispensing (eRD) utilisation
These dashboards provide information on the electronic prescription service and electronic repeat dispensing.
They allow GP practices, CCGs, and other bodies to:
- see the variation in EPS and eRD prescribing across GP practices, within a CCG, and across CCGs
- see trends and variations in EPS and eRD dispensing across dispensers, and within Sustainability and Transformation Partnerships (STPs)
- help prioritise potential areas of activity
- help monitor the impact of initiatives to increase EPS and eRD utilisation
The dashboards support local interventions to help drive the growth of EPS and eRD. This means patients, prescribing organisations such as GP practices, and dispensing organisations such as pharmacies, can experience the potential benefits of the increased use of EPS and eRD.
Evidence-based interventions (EBI)
The Evidence-based interventions dashboard has been updated with List 2 interventions (Word: 246KB).
This provides information about baseline activity and estimated activity reduction goals for 17 interventions targeted by the evidence-based interventions programme.
The dashboard has an activity of 5 or below redacted, in accordance with the Department of Health and NHS England Statistical Policy: Disclosure and Confidentiality policy.
Medication safety indicators
This shows a set of prescribing indicators developed as part of a programme of work to reduce medication error and promote safer use of medicines, including:
Medicines Optimisation Dashboard
Medicines optimisation looks at the value that medicines deliver, making sure they are clinically effective and cost-effective.
The goal of medicines optimisation is to help patients to:
- get the right choice of medicines, at the right time
- access treatment that is clinically effective, based on the latest scientific discovery, at as low a price as possible
- improve their outcomes
- take their medicines correctly
- avoid taking unnecessary medicines
- reduce wastage of medicines
- improve medicines safety
The sandbox area is where we launch ideas and features of new reports and dashboards that are under development.
The first report in this area is the community pharmacy demand dashboard.
To support the coronavirus (COVID-19) preparedness and response, we've created a community pharmacy demand dashboard. This will help identify how many patients are routinely using each pharmacy and how many of those are 70 or over.
You can sort by Area Team, and rank pharmacies in your locality on the variables listed, including:
- Dispenser Code
- Dispenser Name
- Dispenser Postcode
- Total Patients (of all ages)
- Total Items Dispensed (to patients of all ages)
- Total Patients aged 70 or over
- Total Items Dispensed (to patients aged 70 or over)
- Percentage of Patients aged 70 and over
- Percentage of Items Dispensed to Patients aged 70 and over
If you've previously viewed data and reports in ISP, you'll find that there are differences between the data available in Catalyst and ISP.
If you have previously downloaded data from ISP, you'll be unable to replicate the data by running your data from Catalyst.
For more information, view our guide to the differences between the systems (Word: 250KB).
Reports which have previously been available in the ISP through the guest log in have been moved to this new application.
If you have any questions or would like more information, you can contact us.